Medication info

Vitadibon Injection (Cholecalciferol)

Prescription medicationInjectionsIntramuscular injection
Ingredient · strength
Cholecalciferol›5mg / 1mL
Manufacturer / importer
Hyuons Meditech Co., Ltd.
Appearance
A transparent light yellow liquid contained in a brown glass ampoule for injection
Packaging
0.5 mL/ampoule [0.5mL X 10 ampoules], 1 mL/ampoule [1mL X 10 ampoules]
Approval status
Active

MFDS item code 201310948 · Notified 2013.12.30

Summary

Main use
Prevention and treatment of vitamin D deficiency
Who receives it
Adults · Children
Adult administration
Use as prescribed by a physician, and adjust the dose after checking the blood 25-hydroxyvitamin D level. In adults, therapeutic effect and tolerability should be reviewed within 3 months after administration of this medicine, and whether to administer another dose should be decided on this basis. Because adverse reactions increase with overdose, do not administer more than the required amount. - Adults: Administer cholecalciferol 200,000IU by intramuscular injection. - Older adults: Administer cholecalciferol 100,000IU by intramuscular injection. Do not exceed an annual dose of 600,000IU of cholecalciferol.
Child administration
In adolescents, therapeutic effect and tolerability should be reviewed within 6 months after administration of this medicine, and whether to administer another dose should be decided on this basis. - Adolescents: Administer cholecalciferol 200,000IU by intramuscular injection.

Ingredients

Manufacturer
Hyuons Meditech Co., Ltd.

Efficacy & effects

Prevention and treatment of vitamin D deficiency

  • Vitamin D deficiency
View approved original text

This medication is used to prevent and treat vitamin D deficiency in elderly people, adolescents, and adults. It helps maintain skeletal health and reduces the occurrence of bone-related diseases. It is suitable for individuals requiring vitamin D supplementation.

How it is given

Adult administration

Use as prescribed by a physician, and adjust the dose after checking the blood 25-hydroxyvitamin D level. In adults, therapeutic effect and tolerability should be reviewed within 3 months after administration of this medicine, and whether to administer another dose should be decided on this basis. Because adverse reactions increase with overdose, do not administer more than the required amount. - Adults: Administer cholecalciferol 200,000IU by intramuscular injection. - Older adults: Administer cholecalciferol 100,000IU by intramuscular injection. Do not exceed an annual dose of 600,000IU of cholecalciferol.

Child administration

In adolescents, therapeutic effect and tolerability should be reviewed within 6 months after administration of this medicine, and whether to administer another dose should be decided on this basis. - Adolescents: Administer cholecalciferol 200,000IU by intramuscular injection.

Precautions

This drug is an injection that supplements vitamin D, and when used with vitamin D fortified foods or other vitamin D preparations, you must check the total vitamin D intake. Regularly check calcium levels in the blood and urine; if they become too high, administration should be discontinued. Especially in cases of high calcium intake, it is important to monitor calcium concentration more frequently. Be careful to avoid glass fragments when opening the injection container, and caution is especially necessary when using it in children or the elderly. This medication should not be used by individuals with certain diseases or those who are pregnant or breastfeeding. Various side effects such as headaches, fatigue, muscle pain, digestive disorders, hypertension, and kidney issues may occur, so if abnormal symptoms arise, consult a physician immediately. Regularly check blood vitamin D levels and parathyroid hormone levels, and patients with impaired kidney function should have regular kidney function tests. It may interact with other medications, so be sure to inform healthcare professionals if you are taking anticonvulsants, diuretics, antacids, or anticoagulants. Excessive use during pregnancy can harm the fetus, so pregnant and breastfeeding women should not use it. It is advisable not to use in children under 12 years old due to the lack of confirmed safety and efficacy. In the case of overdose, stop administering the medication immediately, reduce calcium intake, and take measures to promote calcium excretion through adequate hydration and diuresis. This drug should not be mixed with other medications, and after opening, it should be used quickly, and any remaining medicine should be discarded. Store in a light-protected, airtight container at a temperature between 1 and 25 degrees Celsius.

Side effects

Headache, weakness, fatigue, myalgia, loss of appetite, weight loss, growth retardation, nausea, vomiting, constipation, diarrhea, polydipsia, polyuria, dehydration, hypertension, calcium stones, calcification of tissues such as kidneys and blood vessels, kidney disorders, excessive bone calcification, arrhythmia, mental symptoms, dissociative disorders, arthralgia, myasthenia, drowsiness, azotemia, hypersensitivity reactions, thirst, confusion, gas bloating, abdominal pain, metallic taste, dry mouth, rash, itching, hypercalciuria, hypercalcemia, hyperphosphatemia, hyperphosphaturia, injection site granuloma, injection site nodules, injection site reactions, injection site urticaria, injection site infections

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light, so it should be stored in an opaque, sealed container. Additionally, it is best to keep it in a cool place at a temperature between 1 and 25 degrees Celsius.

Appearance and packaging

Appearance

A transparent light yellow liquid contained in a brown glass ampoule for injection

Package unit

0.5 mL/ampoule [0.5mL X 10 ampoules], 1 mL/ampoule [1mL X 10 ampoules]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.